SCA
OGN icon

Stuart Chaussee & Associates’s Organon & Co OGN Stock Holding History

Stuart Chaussee & Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30
Closed -$521 – 153
2023
Q3 		$521 Hold
30
– – ﹤0.01% 128
2023
Q2 		$624 Hold
30
– – ﹤0.01% 127
2023
Q1 		$706 Hold
30
– – ﹤0.01% 132
2022
Q4 		$838 Hold
30
– – ﹤0.01% 146
2022
Q3 		$1K Hold
30
– – ﹤0.01% 146
2022
Q2 		$1K Hold
30
– – ﹤0.01% 153
2022
Q1 		$1K Sell
30
-33
-52% -$1.13K ﹤0.01% 161
2021
Q4 		$2K Hold
63
– – ﹤0.01% 168
2021
Q3 		$2K Hold
63
– – ﹤0.01% 145
2021
Q2 		$2K Buy
+63
New +$2.07K ﹤0.01% 155

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Stuart Chaussee & Associates's OGN Position: Q4 2023 in Review

Stuart Chaussee & Associates sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 30 shares — an estimated $521 sold.

Stuart Chaussee & Associates first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $2K in Q4 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Stuart Chaussee & Associates reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 30 Organon & Co shares in Q4 2023, an estimated $521.
  • Stuart Chaussee & Associates first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Stuart Chaussee & Associates's Organon & Co position peaked at $2K in Q4 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Stuart Chaussee & Associates's 13F filing for Q4 2023, filed 2 Feb 2024.